Will it get a taste of CoVID-19 vaccine?

업데이트됨
it was looking poised to reach 270-75 but got some pullbacks in past few weeks, it's looking strong technically and fundamentally (if it also gets some share in the development of vaccine) now though.
노트
it has been trading in a consolidation phase, if it breaks 215 then 287 should be on the cards again.
Technical IndicatorspharmastocksTrend Analysis

또한 다음에서도:

면책사항